top of page

16111269447

Uniquely-licensed supplier of exclusive, high quality, low cost branded cannabis products via established medical clinic partnerships & UK pharmacy contracts. Poised to become a dominant leader in the UK medical cannabis sector!

Licence(s) Held:

• UK: Import, Distribution, Schedule 1 Narcotics, Processing, Online Medical Clinics License
• Channel Islands: Cultivation and Processing License

16111269447

Seeking strategic equity partner to take 20% of the Company for $2.8 million USD

Phase 1

  • Import and distribution of high-quality, low-cost, branded cannabis flower and oil products for UK medical cannabis patients via exclusive UK pharmacy contracts

  • Exclusive contracts with well-established, top ranked Canadian and global medical cannabis producers, with market proven products

  • Access to a large and increasing pool of medicinal cannabis patients through in-house and partner health clinics, pharmacies and other key relationships

  • Product launch via dedicated sales and marketing team, with first revenues in Q4 of 2023

  • Experienced, industry-leading international team with deep expertise in navigating global medical cannabis markets

  • $1M USD projected annual sales in 2023, with $10M USD sales projected in 2024

  • No growing

  • No capital required for infrastructure

  • All licenses in place

  • Turn key operation


Phase 2

  • Expansion of wholesale distribution of branded cannabis flower, oils and derivative products to the European Union and global markets via a partner facility in Ireland.

  • Implementation of in-house EU GMP production in the UK/Channel Islands for direct distribution into the UK and EU markets

16111269447

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal
bottom of page